Please assess the completion status of the following clinical trial:

Trial Title: Comparison of Topical 0.15% Gancyclovir Gel Versus 0.3% Hypromellose Gel for the Treatment of Herpes Zoster Keratitis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* age 18 and above~* have not been on gancyclovir gel or any other form of topical antiviral therapy for the past month~* able and willing to attend subsequent follow-up visits~Exclusion Criteria:~* Associated retinitis~* patients who are allergic to gancyclovir~* patients who will require systemic or intra-vitreal gancyclovir therapy~* patients who are pregnant or breastfeeding

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 95 Years
- Healthy Volunteers: t

Study Arms:
- Gancyclovir gel (Type: EXPERIMENTAL): 0.15% gancyclovir gel to be applied in the affected eye 5 times per day for a week, followed by 3 times per day for an additional 7 days or until the healing of the dendrite, whichever is earlier.
- hypromellose gel (Type: PLACEBO_COMPARATOR): 0.3% hypromellose gel to be applied in the affected eye 5 times per day for a week, followed by 3 times per day for an additional 7 days.

Based on this trial design, predict the completion outcome and termination type (if applicable).